Tuesday, December 23, 2025
When researchers, Dr. Susan Leat and Dr. Elizabeth Irving from the School of Optometry & Vision Science at the University of Waterloo, turned their attention to exploring the commercial prospects of their research associated with the generation of copyright IP in the Waterloo Differential Acuity Test (WatDAT), they approached the Waterloo Commercialization Office (WatCo) for support. The WatDAT test enables early detection of vision disorders in toddlers as young as 18 months, a breakthrough that can significantly improve learning and development outcomes.
Read the full story about WatCo's commercialization success.